iBio, Inc. | Uncategorized | Business Contracts

Exhibit Description (Filed With SEC on March 30, 2023)

Offer Letter by and between iBio, Inc. and Felipe Duran dated January 23, 2023 (Filed With SEC on January 25, 2023)

Form of Series B Warrants (Filed With SEC on December 8, 2022)

Form of Series A Warrants (Filed With SEC on December 8, 2022)

Form of Representatives Warrants (Filed With SEC on December 8, 2022)

Environmental Indemnity Agreement, dated November 1, 2021 by iBio CDMO LLC and iBio, Inc. in favor of Woodforest National Bank (Filed With SEC on November 4, 2021)

Description of Securities of iBio, Inc (Filed With SEC on September 28, 2021)

Second Amended and Restated Right of First Refusal and Co-Sale Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors (Filed With SEC on August 27, 2021)

Director Offer Letter (Filed With SEC on August 26, 2021)

Director Offer Letter (Filed With SEC on June 9, 2021)

Description of Securities of iBio, Inc (Filed With SEC on October 13, 2020)

Statement of Work 2, dated February 6, 2020, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 13, 2020)

Form of Leak-Out Agreement (Filed With SEC on October 28, 2019)

Form of Leak-Out Agreement (Filed With SEC on October 24, 2019)

iBio, Inc. (80) | Uncategorized (14)